Dr. Muneer M  Abidi

Dr. Muneer M Abidi

Address: 1 Ford Pace, Detroit, Michigan, 48202, United States, Wayne State University

Gender: Male

Type of Professional: Oncologist

Associated Healthcare Provider: Henry Ford Hospital

Languages Spoken: English, Urdu

More than 26 Years of experience

About the Doctor / Professional

I have been affiliated with the Division of Stem Cell Transplant and Cellular Therapy Program – Henry Ford Health System since April 2020. Previously, I worked in similar positions at Spectrum Health Cancer Center, Grand Rapids, MI for 6 years and Karmanos Cancer Center/ Wayne State University, Detroit, MI for approximately thirteen years. The Stem Cell Transplant and Cellular Therapy Program uses a comprehensive, multidisciplinary team approach to evaluate and treat patients who are candidates for bone marrow or peripheral blood stem cell transplant. As a Program Director I provide the quality and regulatory oversight. My primary research interest is in developing innovative treatment and supportive strategies for patients undergoing Stem cell transplant. I have been involved as a principal investigator in numerous investigator-initiated, pharmaceutical and cooperative group studies. I have been very actively involved in the Southwestern Oncology Group, Myeloma Committee and was coordinator of a National Clinical Trial, that determined one of the standards of care option for myeloma patients.

Contribution to Science

I have been actively involved in clinical research since 2001. My research interest is focused on designing clinical trials with innovative treatment strategies and supportive care for patients undergoing bone marrow transplant. I have extensively published on these topics in leading medical peer reviewed journal. In addition, I have also presented my scientific work at national and International conferences. I have been actively involved in SWOG myeloma committee since 2003 and have been coordinator of four national myeloma studies. One of these trials was published in Lancet and would change the standard of care. I have also assisted in examining new mobilization strategies for patients undergoing autologous stem cell transplant. My previous work in this field has increased understanding in the use of proteasome inhibitors and demonstrates the need for further work in this important area. 

Research Support

I have received funding for investigator-initiated studies for multiple trials during my career at Wayne State University/Karmanos Cancer Center. I always had one of the highest accrual in the pharmaceutical studies and completed trials successfully after initiation. Recently we had the third highest accrual in a pharmaceutical study at Spectrum Health which was completed in record time.